Literature DB >> 7319133

The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.

D Clayton, A Leslie.   

Abstract

1. Erythromycin plasma concentrations were determined in twenty subjects after a single dose, immediately before food, of erythromycin, 500 mg. as: (1) erythromycin stearate (Erythrocin, 500 mg, ovaloid tablets), and (2) erythromycin base (Eryc, 250 mg, capsules containing enteric-coated pellets). 2. Plasma concentrations were again determined in eighteen of the original subjects with the same dose given immediately after food. 3. Maximum Plasma Concentrations (mcg/ml) (See formula in text) 4. Erythromycin stearate was more bioavailable than erythromycin base when administered immediately before food. The preparations were bioequivalent when given immediately after food.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7319133     DOI: 10.1177/030006058100900608

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Consideration of individual bioequivalence.

Authors:  S Anderson; W W Hauck
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

3.  Reference datasets for bioequivalence trials in a two-group parallel design.

Authors:  Anders Fuglsang; Helmut Schütz; Detlew Labes
Journal:  AAPS J       Date:  2014-12-09       Impact factor: 4.009

4.  Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studies.

Authors:  Helmut Schütz; Detlew Labes; Anders Fuglsang
Journal:  AAPS J       Date:  2014-09-12       Impact factor: 4.009

5.  Effect of concomitant food intake on absorption kinetics of erythromycin in healthy volunteers.

Authors:  T Hovi; M Heikinheimo
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.

Authors:  W W Hauck; S Anderson
Journal:  J Pharmacokinet Biopharm       Date:  1984-02

7.  Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast.

Authors:  A Schreiner; A Digranes
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

Review 8.  Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts.

Authors:  Sonali S Bharate
Journal:  Pharm Res       Date:  2021-07-23       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.